Pharma
Aktiesnakken
TESLA
Genmab
NOVO
Bavarian Nordic
Politiksnakken
Amerikanske aktier
Biotek-snakken
Zealand Pharma
Ennogie
Gubra
Vestas
Shipping
Forsvarsaktier
OLIE OG GAS
Smallcap og First North aktier
GN Store Nord
Hansa Biopharma
Banker og Finans
Pharma
Laks
Medico
AMBU
Chemometec
Embla Medical
![]() |
18/4 09:35 af ProInvestorNEWS |
AbbVie's Rinvoq nabs EU approval in Crohn's disease (link)
|
![]() |
18/4 10:55 af ProInvestorNEWS |
Danske Bank skærer anfaling og kursmål for ALK: Tal svagere end ventet
(link)
|
![]() |
18/4 12:48 af ProInvestorNEWS |
Johnson & Johnson opjusterer forventningerne til 2023 (link)
|
![]() |
18/4 15:09 af ProInvestorNEWS |
Norsk storbank mener nedjusteret prognose hos ALK skaber usikkerhed (link)
|
![]() |
19/4 06:57 af ProInvestorNEWS |
ALK-Abelló/SEB: Kursmål sænkes til 130 kr. fra 140 kr. (link)
|
![]() |
19/4 08:40 af ProInvestorNEWS |
FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines (link)
|
![]() |
19/4 16:26 af ProInvestorNEWS |
Lundbeck når primære endepunkt i migræneforsøg i Hope-studie (link)
|
![]() |
19/4 16:49 af ProInvestorNEWS |
Sydbank kalder Lundbecks migrænemiddel for spændende i stort migrænemarked
(link)
|
![]() |
20/4 06:57 af ProInvestorNEWS |
Forskningsdirektør: Lundbeck tættere på middel mod migræne
(link)
|
![]() |
20/4 07:14 af ProInvestorNEWS |
Har Alk-Abello fået (u)berettiget mange
kursklø? (link)
|
![]() |
21/4 07:00 af ProInvestorNEWS |
Lundbeck får hævet kursmålet hos britisk
storbank (link)
|
![]() |
23/4 14:14 af ProInvestorNEWS |
Is Abbott Laboratories Still a Good Dividend Stock to Buy? (link)
|
![]() |
23/4 14:15 af ProInvestorNEWS |
Is Teladoc Health a Good Stock to Buy Now? (link)
|
![]() |
25/4 07:08 af ProInvestorNEWS |
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
25.4.2023 07.00 • GlobeNewswire •
Ad hoc announcement pursuant to Art. 53 LR
Q1 sales grew +8% (cc
1
, +3% USD) and core operating income grew +15% (cc, +8% USD)
* Innovative Medicines (IM) sales grew +7% (cc, +3% USD) and core operating income +18% (cc, +11% USD)
* IM core margin 38.7%, +360 bps cc, driven by higher sales and productivity programs
|
![]() |
25/4 09:05 af ProInvestorNEWS |
AstraZeneca, Ionis' eplontersen shows sustained benefit on neuropathy impairment, QoL (link)
|
![]() |
25/4 09:14 af ProInvestorNEWS |
FDA expands approval of AbbVie's Qulipta to chronic migraine (link)
|
![]() |
25/4 09:15 af ProInvestorNEWS |
(Lundbeck er på vej i samme indikation)
|
![]() |
25/4 09:16 af ProInvestorNEWS |
Mere migræne : IntelGenx Announces FDA Approval of RIZAFILM for the Treatment of Acute Migraine (link)
|
![]() |
25/4 09:28 af ProInvestorNEWS |
Pfizer bags FDA approval for Zavzpret migraine nasal spray (link)
|
![]() |
26/4 06:20 af ProInvestorNEWS |
FDA Grants Accelerated Approval For Biogen's ALS Drug (link)
|
![]() |
27/4 06:30 af ProInvestorNEWS |
Medicinalsektor kritiserer EU-forslag om revision af regulering (link)
|
![]() |
27/4 06:31 af ProInvestorNEWS |
Novo-topchef ser EU-forslag som "det dummeste jeg har hørt" (link)
|
![]() |
27/4 07:38 af ProInvestorNEWS |
Nordea hæver kursmålet på Lundbeck We raise our revenue estimates by 1-2% going forward, EBITDA estimates by 2% and EBIT estimates by 3-4% – driven by Rexulti and slightly better operating leverage. Our DCF-derived target price is raised to DKK 44 (41) and we remain buyers of the stock
|
![]() |
27/4 10:01 af ProInvestorNEWS |
AstraZeneca Q1 Core Profit Rises, Revenue Ex COVID-19 Up 15% At CER; Reiterates FY23 Guidance (link)
|
| ||
![]() |
27/4 10:02 af ProInvestorNEWS |
GSK's Respiratory Syncytial Virus Older Adult Vaccine Candidate Gets Positive CHMP Opinion (link)
|
![]() |
27/4 10:13 af ProInvestorNEWS |
FDA staff flag concerns over broad use of Lynparza combo in prostate cancer FDA staff flag concerns over broad use of Lynparza combo in prostate cancer
|
![]() |
27/4 10:13 af ProInvestorNEWS |
Orbital bags $270 million to advance RNA-based therapeutics (link)
|
![]() |
27/4 10:14 af ProInvestorNEWS |
Novartis tees up filings for iptacopan in PNH after detailing second study win (link)
|
![]() |
27/4 10:15 af ProInvestorNEWS |
GSK backs full-year view as Q1 sales slip, but top forecasts
(link)
|
![]() |
27/4 10:15 af ProInvestorNEWS |
Vabysmo leads growth in Roche's pharma unit during Q1 (link)
|
![]() |
27/4 13:49 af ProInvestorNEWS |
Eli Lilly stiger efter opjustering trods svagere end ventet indtjening (link)
|
![]() |
27/4 15:41 af ProInvestorNEWS |
Kort video - Pharma og biotek-opdatering UGE 17: Demant ' GN Store Nord ' Novo Nordisk ' Genmab ' Zealand Pharma ' Hansa Biopharma (link)
|
![]() |
27/4 17:02 af Helge Larsen/PI-redaktør |
Is This Big Pharma Stock a Buy for Dividend Investors? (link)
|
![]() |
28/4 10:10 af Helge Larsen/PI-redaktør |
Lundbeck og partner får FDA-godkendelse til skizofrenimiddel (link)
|
![]() |
29/4 06:45 af ProInvestorNEWS |
JP Morgan Maintains Eli Lilly And (LLY) Overweight Recommendation (link)
|
![]() |
29/4 14:42 af ProInvestorNEWS |
Credit Suisse Maintains Ascendis Pharma A (ASND) Neutral Recommendation (link)
|
![]() |
29/4 14:43 af ProInvestorNEWS |
Morgan Stanley Maintains Ascendis Pharma A (ASND) Equal-Weight Recommendation (link)
|
![]() |
29/4 14:44 af ProInvestorNEWS |
Cantor Fitzgerald Maintains Ascendis Pharma A (ASND) Overweight Recommendation (link)
|
![]() |
29/4 14:44 af ProInvestorNEWS |
HC Wainwright & Co. Maintains ASLAN Pharmaceuticals Ltd - ADR (ASLN) Buy Recommendation (link)
|
![]() |
29/4 17:30 af ProInvestorNEWS |
1 No-Brainer Pharma Stock to Buy With $1,000 Right Now
(link)
|
![]() |
30/4 09:04 af ProInvestorNEWS |
Will Pfizer Stock See Higher Levels Post Q1 Earnings? (link)
|
![]() |
30/4 13:10 af ProInvestorNEWS |
AbbVie's Blockbuster Is Falling Fast. Time to Sell? (link)
|
![]() |
1/5 06:37 af ProInvestorNEWS |
Astellas Pharma To Acquire Iveric Bio In $5.9 Bln Deal (link)
|
![]() |
1/5 07:20 af JKY_VH |
"Lundbeck får løftet sit kursmål hos SEB til 37 kr. fra 30 kr., viser data fra Bloomberg. Anbefalingen er uændret "hold".
B-aktien i Lundbeck lukkede fredag i 35,76 kr. efter et fald på 0,3 pct.
.\\˙ MarketWire"
|
![]() |
1/5 09:13 af ProInvestorNEWS |
Teva Recalls FENTANYL Buccal Tablets CII (link)
|
![]() |
2/5 09:55 af ProInvestorNEWS |
Jyske Bank hæver anbefaling for Rockwool forud for regnskab
(link)
|
![]() |
2/5 10:40 af ProInvestorNEWS |
Lundbeck får løftet kursmålet hos norsk finanshus (link)
|
![]() |
2/5 10:43 af ProInvestorNEWS |
FDA Approves First Drug For Anemia In Cats With CKD (link)
|
![]() |
2/5 13:48 af ProInvestorNEWS |
Pfizer rammer over estimater og fastholder forventninger (link)
|
![]() |
3/5 07:20 af LP90 |
Godmorgen :-)
|